Nicotinic acid and psychiatry.
D000368:Aged; D001007:Anxiety / Q000188:drug therapy; D001361:Avitaminosis / Q000150:complications; D001927:Brain Diseases / Q000188:drug therapy / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D006801:Humans; D000860:Hypoxia / Q000150:complications; D001523:Mental Disorders / Q000188:drug therapy*; D008659:Metabolic Diseases / Q000150:complications; D019965:Neurocognitive Disorders / Q000188:drug therapy / Q000209:etiology; D009539:Nicotinic Acids / Q000378:metabolism / Q000627:therapeutic use*; D009748:Nutrition Disorders / Q000150:complications; D010084:Oxidation-Reduction; D010383:Pellagra / Q000188:drug therapy; D010919:Placebos; D011604:Psychoses, Alcoholic / Q000188:drug therapy; D012137:Respiratory System / Q000201:enzymology / Q000378:metabolism; D012559:Schizophrenia / Q000188:drug therapy
D009539:Nicotinic Acids; D010919:Placebos